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Abstract: Some studies have demonstrated that in vivo degradation processes are influenced by
the material’s physico-chemical properties. The present study compares two hydroxyapatites
manufactured on an industrial scale, deproteinized at low and high temperatures, and how
physico-chemical properties can influence the mineral degradation process of material performance
in bone biopsies retrieved six months after maxillary sinus augmentation. Residual biomaterial
particles were examined by field scanning electron microscopy (SEM) and energy dispersive X-ray
spectroscopy (EDX) to determine the composition and degree of degradation of the bone graft
substitute material. According to the EDX analysis, the Ca/P ratio significantly lowered in the residual
biomaterial (1.08 ± 0.32) compared to the initial composition (2.22 ± 0.08) for the low-temperature
sintered group, which also presented high porosity, low crystallinity, low density, a large surface area,
poor stability, and a high resorption rate compared to the high-temperature sintered material. This
demonstrates that variations in the physico-chemical properties of bone substitute material clearly
influence the degradation process. Further studies are needed to determine whether the resorption of
deproteinized bone particles proceeds slowly enough to allow sufficient time for bone maturation
to occur.
Keywords: hydroxyapatite; xenografts; tissue reaction; resorption; biocompatibility;
biomedical applications
1. Introduction
Alveolar bone resorption and pneumatization of the maxillary sinus after tooth extraction limit
the quantity and quality of the bone needed for successful implant placement, especially in the
edentulous posterior maxilla. Many authors have studied posterior maxillary atrophy rehabilitation,
and have reported various maxillary sinus floor augmentation techniques that increase bone volume
and height [1–3]. The maxillary sinus elevation procedure is currently considered the most predictable
of pre-prosthetic surgical techniques. Maxillary sinus grafting, combined with Schneiderian membrane
elevation, has been proposed to re-establish the ideal quantity and quality of bone prior to implant [4].
Grafting material is an important determinant of bone augmentation procedures being a success
or a failure [5]. Ideal bone graft material should be biocompatible [6], increase bone volume in the
grafted area to promote initial stability at implant sites [7], and be resorbed with time and be replaced
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with native bone [8]. The success of scaffold-based bone regeneration approaches strongly depends on
the performance of the biomaterial used. Among the efforts made by regenerative medicine toward
restitution ad integrum, scaffolds should be completely degraded within an adequate period of time.
Degradation of bone grafts substitute materials involves both chemical dissolution (physico-chemical
degradation) and resorption (cellular degradation by osteoclasts) [9]. Based on its physico-chemical
properties, bone-graft material may be either resorbable or non-resorbable in relation to the extent of
dissolution of Ca–P materials [10]. The factors that affect dissolution properties are similar to those
that affect biodegradation or bioresorption [11].
Materials should also be fully degradable and this degradation should ideally match the
osteogenic rate. However, no clear insight has yet been provided as to the exact relationship between
the material properties of these calcium phosphate ceramics and their degradation behavior [12].
Therefore, long-term studies must be carried out to understand the pattern of biodegradation of
xenografts and their influence on bone gain.
An ideal bone graft substitute has long since been sought for problems associated with
gold-standard autologous bone grafts. Although autogenous bone is regarded as the gold standard,
autogenous bone grafts can also exhibit unpredictable bone resorption, which may not be a desirable
characteristic in sinus grafting. Indeed the practice of augmented sinuses using autogenous bone as
the sole grafting material has been shown to undergo significant re-pneumatization and augmented
volume loss according to several clinical reports found in the literature [13–16], which has led to
searches for alternative graft materials. Therefore, the goal is to seek an ideal scaffold that provides
good mechanical support temporarily while maintaining bioactivity, and which can biodegrade
later at a tailorable rate [17]. Several grafting materials have been used for this treatment, but very
few materials are presently considered useful [18]. Synthetic and natural calcium phosphate-based
materials may be a suitable alternative for using autogenous graft [19]. Natural hydroxyapatite
ceramics have drawn attention because it might be possible to use them as an alternative to autogenous
free bone grafting due to their chemical composition and their biological and crystallographic similarity
to the mineral portion of hard tissues [14]. Deproteinized xenografts, primarily constituted of natural
apatites that are sintered or not, have good physico-chemical properties. However, information of
manufacturers’ specifications sometimes contradicts clinical results. Some results have shown that
the examined HA had variable physico-chemical properties, which disagrees with the manufacturers’
specifications. This discrepancy may affect the material’s performance [20]. Many reviews have
discussed a number of biomaterials and their manufacturing processes for biodegradable scaffold
fabrication, but very little work has been done to obtain biomaterials with patient-specific degradation
rates [21–24].
One of the future challenges in bone tissue engineering is to design and manufacture
biodegradable scaffolds with a homogeneous growth rate over their entire volume using pore size
gradients or specific distributions. This requires manufacturing processes with higher resolution and
biofabrication capabilities [25].
Bovine bone has practically unlimited availability and a striking physico-chemical and structural
similarity to human bone [26]. However, some studies have pointed out that this material is not
completely reabsorbable because it will completely disappear within one year. Moreover, the rate
and mechanism of its reabsorption are still unclear [14]. Deproteinized porcine bone mineral has
been recently developed and has become commercially available in maxillary sinus grafting, in which
demineralized bovine bone mineral is widely used [27].
Xenografts are usually of bovine or porcine origin, and are constituted by HA similarly to human
bone (Ca10 (PO4)6(OH)2). This type of graft can be deproteinized and/or demineralized under different
physicochemical conditions, which selectively modulate the tissue response of the host organism [22].
Deproteinization is an indispensable process to eliminate antigenicity in xenograft bones. Valid
strategies to eliminate the antigenicity of xenograft bones are of vital importance for the development
of xenogenic bone graft substitutes [23]. Bone deproteinization methods have to allow the heterologous
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deproteinized bone to offer good biological safety and to meet all the demands of scaffold material
for tissue engineering purposes [28]. Many research works on HA have centered on a wide range of
powder processing techniques, and also on composition and experimental conditions, to determine
the most viable synthesis method [29–32]. Some authors have reported the same observations in
reactions to the microscopic structure in commercial products subjected to thermal deproteinization
processes. Sintering temperature is considered an important factor that could alter the characteristics
of HA [21,33–36]. However, the effect of sintering temperature on the physico-chemical properties of
natural HA (HA of a natural source), especially HA from bovine bone, is not yet fully understood,
and research in this area is still wide open [37]. The most important parameters that can affect the
properties of HA are temperature and heat treatment duration [31].
Regarding the sintering characteristics of HA, the resulting microstructure and properties are not
only influenced by the characteristics and impurities of materials, but are also found to depend on
thermal history during the fabrication process [3].
Some studies have demonstrated that degradation processes are influenced by the material’s
physico-chemical properties [26,38–42]. Different applications require materials with distinct resorption
rates, which can be regulated by a mixture of several calcium phosphate phases [43]. Based on these
data, the objective of this study was to compare the physico-chemical properties of two deproteinized
HA materials, and to assess the influence of these properties on the degradation process of the
material’s performance in retrieved bone biopsies following use in maxillary sinus augmentation.
2. Results
2.1. Characterization of Deproteinized Hydroxyapatite Materials
Figure 1 shows the XRD pattern of the studied deproteinized hydroxyapatite materials, and
the synthetic HA and osseous matrix for comparison purposes. As seen, the deproteinized
bovine hydroxyapatite (DBHa) material presents a high crystalline HA with no other phase, which
corresponds to high-temperature processing. Based on the XRD patterns, the crystal size of the
DBHa xenograft implants is 732 nm. The deproteinized porcine hydroxyapatite (DPHa) material
presents a low crystallinity HA phase (with a crystal size of 325 nm) with broad peaks related to
low-temperature sintering
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Figure 1. Laboratory XRD X-ray powder diffraction pattern of the obtained (A) DBHa and (B) DPHa 
materials, and also (C) the synthetic HA and (D) osseous matrix for comparison purposes. 
Figure 2 includes the FTIR spectra of the obtained DBHa and DPHa materials, as well as the 
spectrum of collagen for comparison purposes. As expected, both the deproteinized HA materials 
show the typical bands brought about by HA, the main constituent of bovine and porcine bone:  
1125–1040 cm−1 (ν3); 963 cm−1 (ν1), and between 550 and 610 cm−1 (ν4). These are the most intense 
phosphate stretching bands observed at around 1043 cm−1 and 1092 cm−1. In addition, a double band 
appears at 1410–1480 cm−1 (ν3) and a low-intensity band at 885 cm−1 (ν2), which correspond to the 
stretching vibrations of CO32−, by substituting for phosphate in the apatite lattice that corresponds to 
natural carbonate-hydroxyapatite [44].  
Figure 1. Laboratory XRD X-ray powder diffraction pattern of the obtained (A) DBHa and (B) DPHa
materials, and also (C) the synthetic HA and (D) osseous matrix for comparison purposes.
Figure 2 includes the FTIR spectra of the obtained DBHa and DPHa materials, as well as the
spectrum of collagen for comparison purposes. As expected, both the deproteinized HA materials
show the typical bands brought about by HA, the main constituent of bovine and porcine bone:
1125–1040 cm−1 (ν3); 963 cm−1 (ν1), and between 550 and 610 cm−1 (ν4). These are the most intense
phosphate stretching bands observed at around 1043 cm−1 and 1092 cm−1. In addition, a double band
appears at 1410–1480 cm−1 (ν3) and a low-intensity band at 885 cm−1 (ν2), which correspond to the
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stretching vibrations of CO32−, by substituting for phosphate in the apatite lattice that corresponds to
natural carbonate-hydroxyapatite [44].
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Figure 3 shows the xenograft materials before insertions for maxillary sinus floor elevation.
The SEM micrographs illustrate major differences depending on heat treatment. DBHa consists of
500–1000 µm average particles with rounded edges and 100 µm pores. At high magnification, the
DBHa material shows a porous surface with white HA crystals (Figure 3A,B). DPHa has HA particles
of about 600–1000 µm on average, with sharper edges and collagen (arrows in Figure 3B,C). Collagen
is attached to the particle’s surfaces or by linking different particles. Figure 3D depicts details of a
sample similar to the previous one, but shows a bundle of collagen over a smooth particle area.
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Figure 3. Scanning electron micrographs of the (A,B) DBHa and (C,D) DPHa xenograft materials
before implantation [arrows = collagen].
EDX also denoted the differences between both xenograft materials (Table 1). The Ca/P ratio
revealed a statistically significant difference in the EDX analysis of grafts before implantation.
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Table 1. Ca/P ratios of grafts before implantation. Values as medians. A statistically significant
difference was found between DBHa and DPHa (Mann–Whitney test, p < 0.0051).
Ca/P Ratios (wt %) DPHa DBHa
Mean 2.22 2.31
SD 0.08 0.09
Median 2.22 2.28
Table 2 provides a comprehensive microstructural characterization of the xenograft materials
and the synthetic HA and osseous matrix for comparison purposes. The tendency was for density to
become higher with increasing heating temperature and lower porosity.
Table 2. The physical characteristics of the two studied xenograft materials and the HA synthetic and
osseous matrix for comparison purposes [HA = hydroxyapatite; Coll = collagen].
Materials
Characterized
Real
Density
(g/cc)
Apparent
Density
(g/cc)
Surface Area
(m2/g)
Total Porosity
(%) a Phase/s
Particle
Size (µm)
Crystal
Size (nm)
DPHa 2.85 1.14 9.78 59.90 HA + Coll 600–1000 325
DBHa 2.98 1.51 2.77 49.13 HA 500–1000 732
HA Synthetic 3.16 1.62 3.10 46.4 HA 600–1000 731
Osseous Matri 1.46 1.24 – 69.3 HA + Coll 400–700 68.4
a Corresponding to 1 µm < pores < 300 µm.
2.2. Results of Retrieved Bone Biopsies
The SEM-BSE cross-sections micrographs six months after the sinus augmentation of both
materials are shown in Figure 3. It is important to highlight the absence of either inflammatory
cells or fibrous connective tissue formation in the vicinity of the xenograft materials and around
the newly formed woven bone, which would otherwise imply bone tissue intolerance to implants.
The behavior of both implants differs. DBHa material is still present in the implantation area after
six months, while the DPHa material is almost degraded.
Figure 4A confirms that the DBHa residual graft particles (*) were surrounded by newly formed
bone, which presented mature bone characteristics, and the EDX analysis supported these findings
(Figure 4). Six months after implantation in the DBHa group, most of the residual biomaterial had been
resorbed. The patterns of resorption at the interface of the DBHa group show resorption regions mainly
on its surface, and a more uneven surface morphology compared with DPHa. The newly formed bone
is found in most of the convex augmented space. Newly formed bone is closely attached to the HA
particles from the implant. For the DPHa xenograft (Figure 4B), behavior differs as an almost complete
resorption zone is observed in them. The patterns of resorption at the interface of the DPHa group
show numerous resorption regions, starting from inside the graft and moving toward its periphery.
The DPHa group has the highest resorption rate compared with the other DBHa group.
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Figure 5 shows the results of the Ca/P ratio of the retrieved bone biopsies following maxillary
sinus augmentation. The EDX analysis indicated a significant decrease in the residual biomaterials (RB)
compared with the initial composition (Table 1). The DPHa shows numerous regions of resorptions,
with an average Ca/P rate of 1.08 ± 0.32 compared with the average Ca/P rate 1.85 ± 0.34 of DBHa.
Statistically significant differences appear between groups at the interface and in new bone. The Ca/P
ratio at the interface is 1.93 ± 0.18 for DPHa compared with 2.14 ± 0.08 of DBHa, and the ratio in new
bone is 1.84 ± 0.14 for DPHa compared with 2.00 ± 0.08 of DBHa. In all cases, a drop in the Ca/P
ratio percentage takes place in the residual biomaterial compared with the initial composition (Table 1),
while the Ca/P ratio percentages gradually increase at the interface, which suggests an increase in the
osteoinductive capacity of the materials and replacement with new bone on their periphery.
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Figure 5. Comparisons between the DBHa and DPHa groups for each parameter (residual bone,
interface, and new bone). The Kolmogorov–Smirnov test rejected normality for all the groups.
Statistically significant differences were found for each parameter between the group comparisons
(Mann–Whitney test, p < 0.0001).
To investigate in detail the distribution of Ca/P in selected areas and individual biomaterial
particles, line scans were carried out with a selection of different points from the implant through the
middle to the periphery of samples to detect changes in the Ca/P ratios (see Figure 5), following the
recommendation of Lindgren [47]. The EDX analysis of the residual graft material particles in the
retrieved tissue revealed Ca/P to be in every variable relative proportion. The analysis indicated that
this individual particle contained Ca/P, which was more concentrated in the interface area. This is
consistent with the replacement of Ca/P with the precipitate as it gradually dissolves.
The data of interest were found in the interface area, where the diffusion of ions was greater.
According to the EDX analysis and the high magnification SEM examination of the interfaces made
between both studied grafts and the surrounding tissue, the reaction zone was characterized by
the intermittent presence of the calcium phosphate phase, which corresponded in structure and
morphology to new bone tissue. The intermediate new bone contained calcium and phosphorous
elements with average Ca/P ratios for DPHa 1.93± 0.18 and DBHa 2.14± 0.08. These results indicated
bone chemical maturity, and reached the stoichiometric Ca/P ratio of natural bone. This compositional
microcharacterization of the interface indicated that the calcium and phosphorous along the periphery
of the implant interfaces remained well textured as the material’s degradation continued inside the
Materials 2017, 10, 542 7 of 19
implant. This led to increased porosity inside the material, which can be observed by comparing the
SEM images of Figure 6. Faster degradation of DPHa compared to DBHa is observed, which is related
with the material’s crystallinity (Figure 1).Materials 2017, 10, 542  7 of 19 
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implantation showing the relative concentration of the principal ions along a line that passes through
a graft biomaterial particle (point 1) and the interface (point 2) to the new bone (point 3) interface
(point 4), and a graft biomaterial particle (point 5). In order to clarify, the scan results are also shown
separately in the figure next to each SEM image.
The SEM image of the polished cross-sections of implants six months after implantation is shown
in Figure 7. The equivalent elemental X-ray maps of calcium and phosphorous are also presented.
At six months after implantation, the outside DBHa implant surface (arrows in Figure 7A) presented
active regions, where the degradation process of the material came about. These observations led to
the conclusion that the interfacial activities at six months were already making full progress, which
resulted in the remodeling of the interface in terms of its morphology and chemistry (calcium and
phosphorous ions). The implant peripheral regions underwent intensive bone resorption, which
produced significantly more irregular surfaces compared with the DPHa implant (Figure 7B). Figure 7B
provides a biopsy of the DPHa-BSE image showing the resorbed DPHa graft in relation to the
surrounding bone, a granular residual material consisting of areas with very few and smaller particles.
These findings indicate the almost complete resorption of DPHa, and similar results in the middle and
on the periphery of samples.
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According to the elemental X-ray maps and the SEM images of the interface between the DBHa
and DPHa implants and natural bone, the reaction zone was composed of Ca and P phases, and was
a short distance away from the reaction zone. No obvious morphological differences were observed
between the newly formed bone and the old bone into which the implants were inserted.
3. Discussion
In the present study, the degradation process of two different xenogeneic bone substitute materials
was evaluated in sinus floor elevation in a split mouth design. Both natural HAs differed significantly
in processing temperature terms as DPHa was a porcine bone graft that was subjected to a low-heat
(130 ◦C) chemical process to extract organic components, while DBHa was a sintered bovine bone
graft that was subjected to high temperature (1200 ◦C). Conflicting results have been reported on the
long-term fate of deproteinized bone. In the literature, the resorption of deproteinized bone has been a
subject of controversy [9,22,37]. The mostly widely mentioned factors in the literature that presumably
govern degradation are crystallography, stoichiometry, and porosity [48].
The manufacturing process, based on high-temperature heating, removes all organic components
and proteins, and eliminates potential immunologic reactions. When deproteinization occurs at very
high temperatures (1200 ◦C), it enhances material crystallinity, which is the case of DBHa [49].
In the present study, and according to the results of research on the effect of sintering
temperature [31], our results reveal that sintering temperature is a critical factor that influences
the phase stability, densification behavior, crystallinity, and porosity of hydroxyapatite ceramics. In
line with other studies, we observed that changes in the composition and crystallinity of calcium
phosphate-based materials from the manufacturer directly affect the clinical result [23] as biomaterials
sintered at high temperature lead to non-absorbable products [9].
If we allowed biomaterials with the same initial particle size range (small size) to be used in both
groups, 600–1000 µm for the DPHa group and 500–1000 µm for the DBHa, then particles might be
degraded biologically or chemically.
The histological examination of 60 biopsies, taken from the 10 patients in this study, indicated
statistically significant differences in the EDX analysis parameters between the DBHa and DPHa graft
materials, and both before and after sinus augmentation. EDX provided information on the chemical
elements present in the graft material and the surrounding tissues which can reveal changes in phase
composition [50]. The purpose of this study was two-fold: to investigate the resorption of these grafts
by examining the appearance of remaining particles by means of these techniques; to observe the
interface between bone and biomaterial to determine whether any changes in the Ca/P ratio caused by
component dissolution during the healing process could be detected in bone biopsies retrieved from
maxillary sinus augmentation. The EDX analysis of the residual graft material particles in the retrieved
bone biopsies six months after an augmented sinus lift revealed a Ca/P ratio in every variable relative
proportion, which is useful for understanding the either resorbable or non-resorbable nature, and this
classification is related to the dissolution extent of the Ca–P materials [10].
In the present study, the Ca/P variations in the graft material were analyzed in both grafts, and a
decrease related to the dispersion of Ca and P through material degradation took place. An analysis
was carried out with a selection of various points in order to take different points of interest from both
the middle and periphery of samples to detect changes in the Ca/P ratios. The EDX analysis monitored
the resorption process of both xenografts. An elemental analysis showed that a gradual diffusion of
the Ca ions from the biomaterial occurred to the newly forming bone at the interface. Very few studies
have used EDX analysis as a tool to understand the degradation process of a biomaterial [51].
According to the EDX analysis, the Ca/P ratio significantly lowered in the residual biomaterial
(RB) compared with the initial composition in the DPHa group, and showed numerous regions of
resorptions in relation to the DBHa group. However when we observed the DBHa group before and
after, we observed a moderate decrease in the residual DBHa compared with the initial composition.
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Changes in the composition and crystallinity of the calcium phosphate-based materials from one
manufacturer to another, or even from different batches of the same manufacturer, directly affect the
clinical result, and are a limiting factor for this material’s use [52].
Natural bone is made up of mainly fine carbonated HA crystals (65%) and collagen matrices (23%)
with an organized three-dimensional geometrical structure, and has many excellent biological and
mechanical properties [53].
Since industries created a self-setting calcium phosphate ceramic with low crystallinity HA,
several commercial calcium phosphate ceramics have become available for clinical therapeutics in
dentistry, such as biomimetic bone materials that contain HA/collagen, with high biocompatibility
and similar characteristics to natural bone. This is the case of DPHa used herein. It is a xenograft
that derives from cancellous-cortical porcine bone. The Tecnoss patented manufacturing process used
to produce these materials achieves biocompatibility by avoiding temperatures above 130 ◦C, which
would cause ceramization of granules by preserving part of the collagen matrix of the original animal
bone. The result is a unique biomaterial that consists in mineral components and a very similar organic
matrix to autogenous bone. According to the study of Kalkura [31], we observed the low crystallinity
structure of the graft and the presence of two phases HA + Col by XRD and FTIR analyses in the
previous characterization of the porcine bone mineral.
Crystallite size is an indication of the material’s crystallinity, which can be defined as the average
size of a domain within a material that has a coherently diffracting monocrystalline structure. By
increasing sintering temperature, the XRD patterns of the deproteinized graft materials exhibited
an increased peak height and reduced peak width, which thus indicates increased crystallinity and
a bigger crystallite size. Crystal size is inversely proportional to peak width. Broadening of peaks
became evident at lower sintering temperatures, which indicates the initial crystal formation state.
At higher sintering temperatures, crystal growth was evidenced by a sharpening to the peaks. For
DPHa, the diffractogram exhibits broad peaks with a low signal-to-noise ratio, which correspond to
a low-crystallinity material. The sharp, well-resolved peaks found in the XRD spectrum of DBHa
indicate highly crystalline HA. So the DPHa sintered at low temperature had a less crystalline structure
compared to the DBHa sintered at high temperature, and could also be more prone to degradation.
Regarding physical properties, density tended to increase with an increasing annealing temperature.
Crystallinity is highly dependent on sintering temperature: the higher the sintering temperature,
the more perfect the crystal and, thus, the lower the degradation rate. Resorption increases with
decreasing crystallinity. Resorbable calcium phosphate materials are usually unsintered Ca–P
materials [54].
Due to the low processing temperature, this material is claimed to preserve the structure and
composition of natural bone components and enhances low crystallinity. Tissues respond differently
to biomaterials with different crystallinities. The major differences in the adhesive response of cells
to different crystallographic structures have been reported [55]. It has been shown that addition
of collagen to HA results in higher bone remodeling activity compared to pure HA. According to
another study, it would appear that addition of collagen to an HA graft could enhance phagocytotic
processes [56].
Nannmark and Sennerby observed relevant significant levels of resorption of collagenized
porcine bone particles [57]. According to these authors, this suggests that presence of collagen
induces osteoclast adhesion to the biomaterial’s surface. Perhaps presence of collagen plays a
key role in initiating resorption. Moreover, the low levels of residual graft material observed in
our study confirmed a substantial resorption of the grafted material after six months, which is an
added advantage for some authors. The elemental mapping of the residual porcine biomaterial at
different points showed some categories of particles with different mean Ca/P ratios according to size.
Compared with the original material composition, significant differences appeared before and after
using DPHs. These findings marked the different resorption process stages. However, other research
works [58] have used transmission electron microscopy of human biopsies following maxillary sinus
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elevation with porcine bone to show a few signs of resorption after five months. Their histological
results indicated only the initial resorption of the biomaterial. Absence of collagen in the porcine
bone used in Orsini’s study could explain its incomplete resorption and would, therefore, support our
hypothesis. In any case, the rapid resorption of porcine bone that contains collagen would appear to
claim an advantage for this material over other biomaterials that do not contain collagen. Other authors
have described this characteristic in studies into HA. When a bone porcine paste, composed of 80%
granulated mix and 20% pure collagen [59], was examined at three months, complete resorption and
substitution with trabecular bone tissue were observed. However in our study, this rapid resorption
was not an advantage as DPHa did not maintain the space and stability in the augmented area of the
maxillary sinus floor.
Regarding porosity, another factor that presumably governs degradation, and is mentioned
frequently in the literature, and also in our characterization study, it is likely that the porcine bone
mineral particles’ microstructure and delicate porous morphology enhance the degradation of this
material [60,61].
Given the low resorption rate of inorganic bovine bone, it has been reported to undergo no,
or limited, resorption [14,62–64]. The present study’s findings are consistent with several reports
found in the literature [65–67] in which an SEM analysis revealed a close relationship between the
newly formed bone matrix and the bovine xenograft particle surface. Although histological and
histomorphometric findings have often corroborated the clinical success of bovine bone mineral,
the published literature includes a few descriptions of its ultrastructural features. The purpose of
our evaluation was to, therefore, add to clinicians’ knowledge of this biomaterial by gaining an
understanding of the interactions that occur in close proximity to bovine bone mineral. The EDX bone
tissue analysis showed presence of calcium and phosphorus, and indicated presence of mineralized
bone tissue on the particle surface. The results demonstrated that Ca ions gradual diffused from
the biomaterial to the newly forming bone at the interface. This observation suggests that the graft
surface might provide an optimal stratum for bone tissue ingrowth [64]. Moreover, the residual graft
material levels observed herein confirmed a substantial resorption of the DBHa biomaterial after six
months. The elemental mapping of the residual DBHa sintered biomaterial at different points showed
some categories of particles with different mean Ca/P ratios according to size. Compared with the
original material composition, a significant resorption of biomaterials was seen to be underway. It
became evident that these findings marked different resorption process stages. In agreement with our
clinical findings, a low osteoclast count over time would explain the long-term (six months, three years,
and seven years) persistence of bovine bone biomaterial [64]. Conflicting results have been reported
on the long-term behavior of bovine xenografts. Early studies reported that bovine xenografts are
non-resorbable [68]. Taylor´s study describes signs of resorption [69], whereas others report that they
are lacking [62,65]. Traini´s study discovered bovine bone biomaterial remnants remaining for as long
as nine years. A follow-up study of sinus floor augmentation with bovine xenografts observed the
gradual diffusion of Ca ions from the bovine xenograft to the adjacent newly forming bone at the
interface as part of the resorption process [67].
However, other [65] studies done with human biopsies following maxillary sinus elevation with
bovine bone have reported few signs of resorption after six months, with histological results indicating
only initial biomaterial resorption. In the current study, we found an incomplete bone graft resorption
phenomenon, whereby the biomaterial was seen to partially decrease. In spite of this limited resorption
capacity, we observed how intergrain boundaries widened, and how the superficial hydroxyapatite
crystallites on the implant surface were partially dissociated. These findings became visible by an
elemental analysis done at different points on the periphery of samples. In the present study, the
sites of interest for a point analysis were randomly selected at the graft site, and it was interesting to
determine whether any differences in the Ca/P ratio could be detected in peripheral or central regions,
as this could indicate different resorption rates. For DBHa, resorption occurred mainly in peripheral
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regions, but the studied DBHa was not completely resorbable during the study period, according to
another study.
According to Moon´s study, which also compared two xenograft materials prepared by a
low-temperature deproteinizing technique (Bio-Oss) or a high-temperature (Cerabone) one in the
sinus cavity, a significantly greater volumetric loss of the initial graft size for the non-sintered material
was observed, which also occurred in our study. Bio-Oss has a significantly larger surface area and
a smaller crystallite size compared with Cerabone [70]. In contrast with Fienitz´s study, a sinterized
material was compared to a non-sinterized bovine bone substitute material by a sinus augmentation
procedure. Despite their histological analysis revealing a lower resorption of the non-sinterized bone
substitute material, the differences found were not statistically significant [71].
In line with our study, in a randomized controlled clinical trial, Lee et al. compared sinuses
grafted with DPBM (deproteinized porcine bone mineral) and DBBM (deproteinized bovine bone
mineral). These authors observed smaller sized residual biomaterials in the histological samples from
the DPBM sites compared to DBBM sites, and despite using the same sizes for both biomaterials [27].
This might have a crucial impact on the resorption rate [43]. Hence, we conclude that the results
of resorption in deproteinized biomaterials varied according to the manufactured process (sintered or
not sintered).
After implantation, biodegradation is critical as this allows for a space to be formed into which
bone and vascular tissues can grow. Biodegradation can be envisioned as an in vivo process by which a
material breaks down into simpler components, which reduces the complexity of chemical compounds
by the action of cells, by simple physical breakdown and/or by chemical erosion [8].
A completely resorbable ceramic has been the goal of several studies. However, a high rate of
resorption or solubilization can interfere with bone formation as the biomaterial may degrade faster
than the rate of bone formation. These phenomena lead to a change in the bioceramic physical structure,
which interferes with cell attachment [72]. Moreover, the release of high concentrations of calcium
to the microenvironment changes pH, promotes a mild inflammatory response, and favors fibrous
tissue formation [73]. Higher calcium ion levels have been shown to effect osteoclastic activity by
varying from its inhibition to its stimulation, or there simply being no effects [74]. Instead presence of
moderate extracellular Ca2+ that results from resorption activity might be involved in the stimulation
of osteoblasts. Yamaguchi et al. showed that moderately high extracellular Ca2+ is a chemotactic and
proliferating signal for osteoblasts, and its stimulates pre-osteoblast differentiation [41].
As DPHa material is the fastest to undergo remodeling, it can be considered the most active in
resorption terms, but not in new bone formation. DBHa seemed to be a gradually resorbed material,
and was partially substituted for newly formed bone according to our results. This increase in ions
could possibly create areas of biological apatite on agglutinated Ca and P deposits and crystals which,
in turn, would facilitate osteoconduction [63].
Some materials, such as autogenous bone, cannot withstand sinus pressure during the first
several weeks and loses density and height over time [16]. An ideal bone graft material should be
biocompatible, increase bone volume in the grafted area to promote initial stability at the implant
sites, and be resorbed with time and replaced with native bone. In this study, DPHa was reabsorbed
so quickly that it was unable to withstand sinus pressure. A repneumatization of sinus, or reduced
augmentation—a phenomenon known as ‘slumping’—was noted [75].
However, the bone resorption process and the distribution of osteoclasts after deproteinized bone
implantation have not been examined in detail, which are relevant for enhancing our understanding
of the complex role of osteoclasts in bone tissue engineering [74].
An in vitro study with osteoclastic precursor cells in bone substitute materials has shown that there
are specific parameters that inhibit or enhance resorption. Moreover, analyses of the bone–material
interface have revealed that biomaterials composition significantly influences their degradation when
they come into contact with osteoclasts. The crystallinity, grain size, surface bioactivity, and density of
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the surface seem to have a less significant effect on osteoclastic activity. In addition, the topography of
the scaffold surface can be tailored to affect the development and spread of osteoclast cells [75].
This suggests that resorption of collagen deproteinized bone material occurs more quickly
than bone formation. Collagen is absorbed mostly by enzymatic digestion. It is noteworthy that
TRAP-positive osteoclastic cells have been seen on the surface of deproteinized collagen. This implies
that collagen fibrils are resorbed not only enzymatically, but also phagocytically. This was the case of
the non-sintered DPHa [76]. Our study showed that most of the newly formed bone in the augmented
sinus spaces grafted with DPHa had disappeared six months after implantation, which caused the
repneumatization of the sinus.
The study of Galindo et al. (2012) found that the osteoclast count significantly lowered, and a
true reduction in biodegradation [77]. Further long-term studies are needed to determine whether
resorption of deproteinized bone particles proceeds slowly enough to provide sufficient time for
bone maturation to take place. Our results demonstrate that slowly resorbed sintered DBHa particles
promoted stable maxillary sinus floor augmentation and inhibited the resorption of newly formed
bone, maintained the space, and stably augmented the maxillary sinus floor. The newly formed bone
showed minimal osteoclastic resorption. The slow biodegradation of DBHa bone particles tented
the sinus lining, maintained the space, and stably augmented the maxillary sinus floor. Therefore,
we conclude that DBHa bone particles can be successfully used as a bone graft material for sinus
lift procedures.
The grafting material is an important determinant of bone augmentation procedures being a
success or a failure. With the various bone grafting options available to surgeons, one must carefully
match the clinical problem and the graft material’s capabilities. The sintering process provides strength
to a finished material. However, when applied to bone, one of the most important factors is the
possibility of materials being resorbed and substituted for newly formed bone.
This study assumed the difference in the physico-chemical properties between the influence of
both grafts on the biological response produced by a biomaterial, and significant differences were
found in relation to the degradation process after six months of healing. According to others studies,
phase composition [78], chemical composition [79], porosity [80], the dispersant concentration on
the pore morphology [58], particle size [81], the ultrastructural geometry of particles [82], surface
roughness [83], and crystallinity [17], among others, are likely to affect ceramic solubility. Different
applications require materials with distinct resorption rates [9], which may be adjusted for the desired
purpose [84].
4. Materials and Methods
4.1. Deprotenized Hydroxyapatite Materials
The raw materials employed in this study were two different types of commercial deprotenized
HA materials used in dentistry: deproteinized porcine hydroxyapatite (DPHa) processed at 130 ◦C
called OsteoBiol®, deproteinized bovine hydroxyapatite (DBHa) processed in two steps: pyrolysis at
900 ◦C following ceramization at 1200 ◦C called Endobon®.
The mineralogical characterization of the powder materials was performed by X-ray
diffractometry (XRD). XRD patterns were obtained in a Bruker-AXS D8Advance (Karksruhe, Germany)
automated diffractometer and were compared with the database provided by the Joint Committee
on Powder Diffraction Standards (JCPD). The following Scherrer formula was used to determine the
crystal size of each material based on the relevant XRD pattern. Instrument broadening corrections
were taken into account, and it was assumed that the lattice strain was negligibly small.
Dhkl =
kλ
B 1
2
cosθhkl
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In this equation k is the Scherrer constant (0.89), which depends on crystal shape, the diffraction
line indexes [85] and the dispersion of the crystallite sizes of the powder [86]; is the wavelength of Cu
Kα1 (λ = 1.54056 Å); B1/2 corresponds to full width at half maximum (rad) for (hkl) reflection; and θhkl
is the diffraction angle (◦). The line broadening of the (300) reflection that corresponds to the maximum
intensity peak was used to evaluate crystal size.
The particles´ real density (sample mass/volume of the solid (excluding empty spaces) was
determined by helium-gas pycnometry (Quantachrome Instruments, Boyton Beach, FL, USA) and
the particles´ apparent density was determined by mercury porosimetry. Particles´ real density was
determined after excluding sample interstices and most pores since the small volume of the gas
molecules (He) enables their penetration in almost all the empty spaces. One exception was samples’
closed pores, i.e., those pores that do not open out to the surface. Density, measured in this way,
provides the closest value to the sample’s solid density, which justifies the use of the term ‘real’ or
‘true’ density.
Microstructural examinations were done under a scanning electron microscope (SEM, HITACHI
S-3500N, Ibaraki, Japan). Quantitative analyses were run by an Energy Dispersive X-ray Spectroscopy
(EDX) system, coupled to the above-described electron microscope. Calibration was carried out with
Bayer standards. A weight percentage was calculated from the measured net intensities with a program
that corrects for the influences of atomic number, absortion, and fluorescence (ZAF corrections).
Relative counting error εn was calculated as εn = (N1/2/N)·100 (N = accumulated counts) with a
probability of 98.5%.
Fourier transform infrared spectroscopy (FTIR-ThermoNicolet IR200, Waltham, MA, USA) was
used to provide information on the chemical composition and major functional groups. FTIR spectra
were recorded between 400 and 4000 cm−1 at 2 cm−1 resolution. Pellets were prepared by mixing each
sample powder with the KBr matrix at a level of 1 wt %. Background data were collected for the KBr
matrix and subtracted from each spectrum. All the spectra were recorded at ambient temperature.
Analytical-grade collagen samples (purchased from Sigma-Aldrich, Darmstadt, Germany) were also
used for comparison purposes.
4.2. Surgery and Bone Retrieval
Ten partially edentulous patients (six women and four men), whose ages ranged from 41 to
71 years, came to the Department of Oral and Maxillofacial Surgery, who had <5 mm subantral alveolar
bone in the vertical direction, determined by conventional tomographic radiography. They were
treated by a maxillary sinus floor augmentation procedure and delayed implant placement. Patients
who received treatment with bisphosphonates or steroids, those currently undergoing chemotherapy
and/or radiation to the oral cavity, and those with uncontrolled systemic disease or endocrine disorders
were excluded from the study.
The protocol for harvesting bone samples was approved by the University Ethics Committee
and informed consent was obtained from all patients. This study is consistent with the ethical
principles set out in the Declaration of Helsinki for experimentation on human subjects. All the
patients received antibiotics prior to surgery. Each subject was required to take 2 g of amoxycillin 1 h
prior to surgery. For any patient allergic to amoxycillin, 600 mg of clindamycin were administered
1 h before surgery. All the surgical procedures were performed under local anesthesia (lidocaine
hydrochloride 2% with 1:100,000 epinephrine or mepivacaine/carbocaine 3%, without epinephrine).
Maxillary sinus augmentation was performed as previously described Tatum [79]. The grafts material
was carefully packed in the space created by mucous membrane elevation. DBHa was placed in a
subantral compartment and DPHa was placed in the contralateral subantral compartment. Upon
implant surgery, and six months after the healing period, a biopsy was taken for histology purposes at
the time of implant placement. Bone cores were harvested using a 3 × 10 mm diameter trephine bur
under sterile saline solution irrigation conditions. Sixty bone samples were retrieved for the analysis.
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Two biopsies per individual were obtained. Nevertheless, the biopsy value we used in our analysis
was unique for each individual and was computed as the average value of its biopsies.
4.3. Specimen Preparation and Analysis
In order to investigate the relationship between xenograft biomaterial particles and bone,
cross-sections of the non-decalcified tissue were examined for an ultrastructural study in SEM-EDX.
Human specimens were fixed by immersion in 4% formalin solution, dehydrated in a graded ethanol
series, and embedded in plastic resin (Technovit A 7210VCL; Kulzer & Co., Hanau, Germany). Then
specimens were polished by a manual grinder with 800 grit silicon carbide paper, mounted on an
aluminum stub, and carbon-coated in an argon atmosphere with a sputtering machine (Polaron K550X
Sputter Coater, Laughton, UK) for the SEM-EDX analyses. Back-scattered SEM imaging (BSE) was also
employed to highlight the contrast among the resin, bone, and biomaterials; generally, resin appeared
black, bone was gray, and the biomaterial had a brighter contrast than bone. In addition, the chemistry
of the interphases and the chemical degradation process of the xenograft biomaterials were analyzed
using X-ray elemental maps in the scanning mode. An analysis was carried out by selecting different
points, and by taking distinct points of interest from both the middle and the periphery of samples
to detect changes in the Ca/P ratios. Data were then collected from deliberately targeted sites of
interest from within the residual biomaterial, which were close to and distal from new bone, and also
at the bone-implant interface if present (on average, approximately 15 points/section, depending on
biomaterial content). Additional information was obtained from line scans and elemental maps. More
than 900-point analyses were carried out on the 60 biopsies.
4.4. Statistical Analysis
The statistical analysis was performed by the computerized statistical package software (MedCalc
v15.8, Ostend, Belgium). Comparisons between the DBHa and DPHa groups for each parameter (RB,
INT, and NB) were made by the Student´s t (parametric data) or Mann–Whitney (non-parametric
data) tests.
5. Conclusions
The fastest resorption rate of the material was in DPHa group and was related to physico-chemical
characteristic of this xenograft material. A significant difference in resorption time and in the stability
of the material was found in DBHa, which showed greater stability and less resorption than the DBHa
groups. The HA of porcine origin non-sintered with high porosity, low cristallinity, low density, high
surface area, and low calcium/phosphate ratio presents low stability and high resorption rate.
This study demonstrates that variations in the physical properties of a bone substitute material
clearly influence in the degradation process, as a consequence, biomaterials can be designed to demand
depending on the needs of resorption, dimensional stability, and handling needed for each case.
Further studies are required to establish to what extent the acceleration or slow-down of resorption
phenomena affects the capacity of the bone augmentation area to receive and integrate dental implants.
Our results demonstrate that slowly resorbed deproteinized bovine bone particles promote the stable
augmentation of the maxillary sinus floor and inhibit the resorption of the newly formed bone.
This study demonstrates the effect of sintering temperature on the physico-chemical properties of
natural HA and the influence on the degradation process. A significant difference in the resorption
time and the stability of the material was found in both groups. The DPHa non-sintered HA with high
porosity, low crystallinity, low density, large surface area, and a low calcium/phosphate ratio presented
a high resorption rate, but could not withstand sinus pressure. This led to the repneumatization of the
sinus. The DBHa sintered HA showed low porosity, high crystallinity, high density, small surface area,
and a high calcium/phosphate ratio, and presented a slow resorption rate that inhibited the resorption
of the newly formed bone, tented the sinus lining, maintained the space, and stabilized an augmented
maxillary sinus floor.
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